CanCan research has been recognized and supported by several grants, including Innovate UK ICURe grant, and 3x BBSRC Campus Innovation Grants, and received the Scottish 2026 “Innovation: Animal Health, Agritech, and Aquaculture” Life Sciences Award.

Our culture and research are rooted in academia, and we participate in numerous research projects with universities, including the following clinical trials:

• Mast cell tumours- University of Florida, USA  (https://research.vetmed.ufl.edu/comparative-molecular-analysis-for-acquired-toceranib-resistance-in-dogs-with-mast-cell-tumors-mcts/)
• Histiocytic sarcoma- University of Florida, Michigan State University, both USA (https://research.vetmed.ufl.edu/phase-ii-open-label-non-randomized-multicenter-clinical-trial-of-trametinib-for-dogs-with-histiocytic-sarcoma/)
• Mammary carcinoma- Uppsala University, Sweden
• Sarcomas- University of Zurich, Switzerland
• Urothelial carcinoma – Purdue University, USA (finished, manuscript in preparation)